BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71
13 results:

  • 1. p53 Is Regulated in a Biphasic Manner in Hypoxic Human Papillomavirus Type 16 (HPV16)-Positive Cervical cancer Cells.
    Zhuang L; Ly R; Rösl F; Niebler M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333786
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial cancer Patients at Rajavithi Hospital.
    Prueksaritanond N; Cheanpracha P; Yanaranop M
    Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Downregulation of tumor suppressor gene pml in uterine cervical carcinogenesis: impact of human papillomavirus infection (HPV).
    Singh N; Sobti RC; Suri V; Nijhawan R; Sharma S; Das BC; Bharadwaj M; Hussain S
    Gynecol Oncol; 2013 Mar; 128(3):420-6. PubMed ID: 23220564
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A postulated role of p130 in telomere maintenance by human papillomavirus oncoprotein E7.
    Zhang W; Tian Y; Chen JJ; Zhao W; Yu X
    Med Hypotheses; 2012 Aug; 79(2):178-80. PubMed ID: 22595804
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fluorescence in situ hybridization of three oncogenes on a leiomyoma.
    Faruqi SA; Saquib M; Harsch C; Noumoff JS
    Microsc Res Tech; 2012 Aug; 75(8):1147-9. PubMed ID: 22593003
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Insulin-like growth factors II exon 9 and E-cadherin-pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma.
    Hsieh YY; Chang CC; Wang YK; Hsu KH; Chen CP; Hsu CM; Tsai FJ
    Anticancer Res; 2010 Jun; 30(6):2203-8. PubMed ID: 20651370
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.
    Lin Z; Yemelyanova AV; Gambhira R; Jagu S; Meyers C; Kirnbauer R; Ronnett BM; Gravitt PE; Roden RB
    Am J Pathol; 2009 Jan; 174(1):136-43. PubMed ID: 19095951
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
    Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Promyelocytic leukaemia (pml) protein expression in human placenta and choriocarcinoma.
    Kim CJ; Yoon BH; Jun JK; Park JO; Cho SY; Romero R; Kim YM; Yu ES
    J Pathol; 2003 Sep; 201(1):83-9. PubMed ID: 12950020
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.
    Pulsoni A; Pagano L; Lo Coco F; Avvisati G; Mele L; Di Bona E; Invernizzi R; Leoni F; Marmont F; Mele A; Melillo L; Nosari AM; Pogliani EM; Vignetti M; Visani G; Zagonel V; Leone G; Mandelli F
    Blood; 2002 Sep; 100(6):1972-6. PubMed ID: 12200354
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Interferon-beta induces S phase slowing via up-regulated expression of pml in squamous carcinoma cells.
    Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
    Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. pml nuclear bodies are general targets for inflammation and cell proliferation.
    Terris B; Baldin V; Dubois S; Degott C; Flejou JF; Hénin D; Dejean A
    Cancer Res; 1995 Apr; 55(7):1590-7. PubMed ID: 7882370
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The incidence of HPV in a Swedish series of invasive cervical carcinoma.
    Hagmar B; Johansson B; Kalantari M; Petersson Z; Skyldberg B; Walaas L
    Med Oncol Tumor Pharmacother; 1992; 9(3):113-7. PubMed ID: 1341323
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.